Arkolith/Insider Trading/CAPR/Form 4

Marban Linda

CHIEF EXECUTIVE OFFICER, DirectorCAPRICOR THERAPEUTICS, INC. (CAPR) · full profile →Form 4 · filed Mar 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2025Other(J)13K—$0211K
Mar 3, 2025Option exercise(M)25K$1.39$35K224K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Option exercise(M)25K—$00

Transaction Codes

J
Other acquisition / disposition
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006986) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML